Latest Orphan drug Stories
SAN DIEGO, Aug. 5, 2014 /PRNewswire/ -- Genoa Pharmaceuticals, the leader in inhaled medicines for pulmonary fibrosis, today announced the U.S.
Significant company milestones include completion of the Phase 2 PUNCH(TM) CD clinical trial and FDA designation of RBX2660 as Orphan Drug and Fast Track ROSEVILLE, Minn., Aug 4, 2014
BELLEVILLE, ON, July 29, 2014 /PRNewswire/ - Bioniche Life Sciences Inc.
- Neurotrope enters into world-wide, exclusive license agreement with Mount Sinai; Files related provisional patent for Bryostatin-1 - PLANTATION, Fla., July 22, 2014 /PRNewswire/
ROCKVILLE, Md., July 7, 2014 /PRNewswire/ -- CASI Pharmaceuticals, Inc.
LONDON, July 2, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
PARIS, June 23, 2014 /PRNewswire/ -- Pharnext SAS today announced that the European Medicines Agency (EMA) and the U.S.
In an environment where orphan drug development is on an all-time high and Contract Research Organizations are in demand, orphan reach, who pioneer a unique global patient access solution, has
LONDON, June 18, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
- An imitative word; an onomatopoetic word.